A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types
2018 · npj Precision Oncology · 210 citations
https://doi.org/10.1038/s41698-018-0051-4
C
Christiaan Klijn
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
141
Papers
4.6K
Citations
29
h-index
36
i10-index
Christiaan Klijn is an academic researcher from Genmab (United States). The author has contributed to research in topics: Cancer Genomics and Diagnostics & Cancer Cells and Metastasis & Biotechnology and Related Fields. The author has an h-index of 29, co-authored 120 publications.
ORCID: 0000-0003-0878-4121Papers by this author
worksRecurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers
2016 · Cell Reports · 207 citations
https://doi.org/10.1016/j.celrep.2016.08.010
Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer
2014 · Nature Communications · 95 citations
https://doi.org/10.1038/ncomms4830
Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma
2017 · Nature Genetics · 72 citations
https://doi.org/10.1038/ng.3905
Specific genomic aberrations in primary colorectal cancer are associated with liver metastases
2010 · BMC Cancer · 39 citations
https://doi.org/10.1186/1471-2407-10-662
Molecular alterations associated with liver metastases development in colorectal cancer patients
2011 · British Journal of Cancer · 30 citations
https://doi.org/10.1038/bjc.2011.184
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat